Table 2. Treatment-emergent adverse events occurring in ≥10% of study patients.
| Adverse event, n (%) | All patients, N=88 |
|---|---|
| Abdominal pain | 30 (34) |
| Catheter sepsis | 25 (28) |
| Episodes of weight decrease | 22 (25) |
| Asthenic conditions | 20 (23) |
| Febrile disorders | 18 (20) |
| Nausea | 17 (19) |
| Urinary tract infections | 16 (18) |
| Catheter site-related reactions | 15 (17) |
| Upper respiratory tract infections | 15 (17) |
| Abdominal distension | 14 (16) |
| Diarrhea | 13 (15) |
| Musculoskeletal pain | 13 (15) |
| Gastrointestinal stomaa complications | 12 (33) |
| Dehydration | 12 (14) |
| Fluid overload | 12 (14) |
| Headaches | 10 (11) |
| Hypersensitivity | 9 (10) |
| Muscle spasms | 9 (10) |
| Flatulence | 9 (10) |
| Vomiting | 9 (10) |
a
Only among patients with stoma (n=36).